Evaluating the Efficacy and Safety of Direct Oral Anticoagulants Compared to Vitamin K Antagonists in Patients with Antiphospholipid Syndrome: Updated Systematic Review and Meta-Analysis

Background Antiphospholipid Syndrome (APS) is an autoimmune condition that increases thrombosis risk. Although Vitamin K antagonists (VKA) are standard treatment, interest in direct oral anticoagulants (DOAC) has grown. Recent studies evaluated DOAC across all APS subgroups. This review updates our...

Full description

Bibliographic Details

Published in:	Clinical and Applied Thrombosis/Hemostasis
Main Authors:	Lama Alfehaid PharmD, MME, Nada Alsuhebany PharmD, Hussah Albahlal PharmD, Albatoul Alomran PharmD, Abdulmajeed M Alshehri PharmD, Mohammed AlSheef MD, Abdulaali Almutairi PharmD, PhD
Format:	Article
Language:	English
Published:	SAGE Publishing 2025-08-01
Online Access:	https://doi.org/10.1177/10760296251364269